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ABSTRACT 
The relationship between movement and pain related fear, function, and depression in chronic pain 
patients 
Melissa Joy Roumanis 
Chronic pain affects multiple facets of a person’s life. Interdisciplinary programs are effective in 
treating chronic pain, but approaches used to improve function are different between programs. It is 
unclear which aspect of rehabilitation is responsible for improving function. In these programs, patients’ 
allocation to groups and post program assessments are based on subjective and self-report evaluations 
from the patients. The purpose of this study was to objectively evaluate chronic pain patients’ day and 
night movement to see the relationship between movement to baseline and final outcomes in pain 
related fear, function, depression, and pain. Twenty-four patients were diagnosed with chronic pain and 
wait listed for a chronic pain rehabilitation program (age=48.1±11.8years, weight=76.2±21.2kg, 
height=164.6±7.3cm). There were two groups at this rehabilitation center, specialized (S) and super-
specialized (SP), 12 patients in each group. Patients’ pain related fear, function, depression, and pain 
was assessed prior to the starting the program and at the completion of the 9-week program.  Day 
movement and night movement were monitored for 7 days prior to starting the program using 
actigraphy. All pain related fear, function, depression, and pain variables significantly improved upon 
completion of the program. Movement during the day was significantly related to self-reported 
function, but not to the 6-minute walk test. Moreover, movement during the day was correlated with 
depression and pain. In conclusion, day and night movement cannot be used to predict successful 
completion of the program. Clinicians should use self-reported and objective function measurements to 
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Chronic pain is a debilitating condition affecting multiple facets of a person’s life. Chronic pain is 
characterized by reoccurring pain extending beyond three months.33 In addition, chronic pain can 
include a variety of conditions such as, fibromyalgia, musculoskeletal pain, arthritis, and chronic joint 
symptoms (CJS). Arthritis and CJS are the most common chronic conditions, affecting 70 million U.S 
adults aged ≥ 65 years in 2001.14 U.S adults with arthritis and CJS are the leading cause of disability in 
the U.S and the number of people ≥65 years will double by 2030.14 A total cost of $128 billion dollars 
was attributed to arthritis and other rheumatic conditions in the U.S in 2003.14 
Chronic pain affects a person physically, mentally, and socially.31 Interdisciplinary rehabilitation 
programs are the leading option for treating chronic pain patients because all three aspects are 
addressed throughout treatment.31 Although interdisciplinary programs have proven to be successful, 
the approach used to improve function and quality of life are quite different between the programs.31 It 
is unclear which specific intervention used during rehabilitation is the primary factor and which 
addresses the improvement in function the best. In some programs there are different specific 
rehabilitation options with regards to treatment. In these programs, patients’ allocation to groups and 
post program assessments are based on subjective evaluations of physical and emotional stability.71 
When there is more than one treatment option, there is a need for an accurate baseline assessment to 
determine which group or program the patient will be placed. There are few objective variables that can 
be measured in this case to determine group allocation. Part of the reason why there are few objective 
measures for chronic pain patients, is because pain is subjective. However, the amount of movement or 
activity can be measured objectively and has been correlated to depression and function.37  
Physical activity is commonly affected in chronic pain patients and can be easily measured.20 
Previous research suggests chronic pain patients may be less active during the day.42 Physical activity is 





during the day is measured among people with depression to evaluate the severity of depression and 
determine impairment.42 The lower the amount of activity the more depressed a person may be. 
Chronic pain patients also have a low level of day activity due to their pain and potentially their 
depression as well. Since movement is correlated to depression and function, it is possible that chronic 
pain patients’ movement, prior to rehabilitation, will be related to their starting measures of function 
and depression. Furthermore, patients’ movement prior to starting the program may indicate how 
successful they will be in the program.  
A clinical prediction rule is a guide or a test used to enhance practitioners’ decision making of 
patient management.54 For example, clinical prediction rules assist decision making for the use of 
imaging for the diagnosis of ankle, knee, cervical, and minor head injuries.72-74 Furthermore, clinical 
prediction rules have not only been used for diagnosing, but help decide who will respond to a particular 
intervention successfully.32, 54 A clinical prediction rule was developed for low back pain (LBP) due to 
array of treatments, the rule was developed to see who would benefit from spinal manipulative therapy 
(SMT).12 Patients meeting at least four of the five criteria qualified for SMT and had a success outcome 
of 92%.12 Patients meeting fewer than three of the criteria only had 7% success rate with SMT, indicating 
the need for alternative treatment.12 To date, there is no evidence supporting a clinical prediction rule 
for the management of chronic pain. A clinical prediction rule based on the amount of movement either 
during the day or at night could determine the severity of dysfunction at the beginning of the program 
and potentially could correlate to the successful completion of the program. A clinical prediction rule 
could be one of the few objective measures used for chronic pain patients to help allocate patients into 
groups and determine success of interdisciplinary rehabilitation programs.  
   As mentioned previously, there are numerous ways to treat chronic pain and each program 
varies. 31 Furthermore, the assessments within an interdisciplinary program are based on subjective 





the few variables that can be measured objectively and is correlated to depression and function. Chronic 
pain patients’ movement could be used as a clinical prediction rule that could help determine who will 
react successfully to a particular treatment. The purpose of this study was to evaluate chronic pain 
patients’ movement during the day and night to see if there is a relationship between the movement 
prior to the program to baseline and final outcomes which include pain related fear, function, 
depression, and pain.  
Literature Review: 
Interdisciplinary Rehabilitation Programs and Chronic Pain 
Pain is viewed as a multidimensional phenomenon involving sensory, affective, motivational and 
cognitive components.63 Due to pain being viewed as multidimensional, chronic pain is regarded as 
multidimensional.31 Chronic pain affects a person physically, mentally, socially, and occupationally. 31 
The treatment of chronic pain use to be done by a single discipline treatment, such as medical therapy 
or physical therapy.63  The current treatment for chronic pain, however, has shifted to interdisciplinary 
rehabilitation because chronic pain affects multiple facets of a person’s life.24 
Interdisciplinary programs combine individual and group-based therapies such as physical and 
occupational therapy, psychology, relaxation therapy, counseling, vocational rehabilitation services, 
nursing education, and aerobic rehabilitation.71 Even though a patient is involved in an interdisciplinary 
program the patient is seen by many disciplines, all disciplines share common values and goals for the 
patient. 71 The goals include promotion of self-management perspective, relaxation skill training, 
cognitive restructuring, behavioral activation (goal setting), problem solving, increase knowledge on 
postural hygiene and stress management. The therapies focus on integrating the new knowledge into 





prevention.71 Each discipline has a clearly defined role but interdisciplinary programs emphasizes 
integrating skills from one discipline into another.71  
The American Pain Society (APS) has developed evidence-based components for effective care 
in interdisciplinary rehabilitation programs.  The first component is assessment. The assessment of a 
patient should include various team members and is an ongoing process throughout treatment.81 How 
the treatment plan is executed is important among interdisciplinary programs. Disciplines involved in 
care collaborate and commence in unison.81 The second critical part to an interdisciplinary rehabilitation 
program, is communication.81 Communication does not only occur between the disciplines involved, but 
also between the patient, family, and significant others.81 The third component is proper 
documentation.81 Proper documentation is essential when many disciplines are involved to establish 
progress towards short-term and long-term goals.81 Education to third-party payers is an important 
component in  interdisciplinary pain care as well because negotiations may be required to obtain third-
party support.81  Follow-up care is the final component of interdisciplinary programs. After patients are 
discharged from care, patients, caregivers, and significant others are provided with appropriate 
information on continuing care plans, maintenance and strategies for addressing relapse symptoms.81 
The Mayo Clinic Pain Rehabilitation Center, The rehabilitation Institute of Chicago and The 
Cleveland Clinic are three established institutions with interdisciplinary rehabilitation programs. These 
programs are good examples of how interdisciplinary programs address multiple factors that influence 
the chronic nature of chronic pain patients.  
The Mayo Clinic Pain Rehabilitation Center located in Rochester, Minnesota uses an 
interdisciplinary rehabilitation program. The center is a tertiary hospital-based outpatient program and 
has existed since 1974.71 The program admits new patients yearly and treats 25 patients daily.71 Patients 
go through a treatment consisting of a three week intensive (120 hours) program from 8AM-5PM.71 





physical and emotional stability, treatment goals, medication, and an agreement not to pursuit further 
medical or surgical interventions.71 After evaluations, patients are divided into two treatment groups. 
One rehabilitation group focuses on functional restoration.71 The other group receives rehabilitation 
plus substance use education for patients who are at risk for substance abuse.71 Both groups go through 
15 treatment days (8AM-5PM), daily supervised physical exercise, and 10 hours of family/support group 
education sessions per week.71 Assessment of physical and emotional functioning upon admission and 
discharge includes the Multidimensional Pain Inventory (MPI), a measure of pain severity and suffering 
level, Short Form-36 Health Status Questionnaire (SF-36), Center for Epidemiologic Studies-Depression 
(CES-D) scale, Pain Catastrophizing Scale (PCS), Pain Self-Efficacy Questionnaire (PSEQ), Pain Anxiety 
Symptoms Scale (PASS), Canadian Occupational Performance Measure (COPM), personality assessment, 
and a brief structured interview to identify major psychiatric disorders 71. 
 The Mayo Clinic Pain Rehabilitation Center published outcomes reporting the efficacy of 
treatment.79 The purpose of the longitudinal study was to assess chronic pain patients using opioids to 
chronic pain non-opioid patients after completing the interdisciplinary program.79 The total study 
population was 373 patients and the patients were divided into two groups.79 One group of 213 patients 
taking opioids on admission was compared to 160 non-opioid patients at the time of admission.79  
Patients taking opioids averaged 99.0mg/day of morphine.79 Chronic back pain, fibromyalgia and chronic 
headaches/migraines were the primary pain conditions for both groups.79  The average number of years 
patients complained of pain was nine years.79 On admission, all patients completed the questionnaires 
as mentioned earlier to measure pain severity, pain interference, level of function, life control, 
depression, pain catastrophizing, and pain-related anxiety.79 Two hundred and thirty-eight patients 
completed the 3-week interdisciplinary program. The patients taking opioids at the time of admission 
completed the 3-week program as well as opioid withdrawals.79 On admission, patients taking opioids 





the program, improvements were seen in pain severity, mood, pain catastrophizing, and functioning 6 
months post-treatment regardless of the opioid admission status.79 
Another interdisciplinary program is the Brooks Pain Rehabilitation Program located in 
Jacksonville, Florida. The facility treats an average of 8 patients a day.71 Brooks Pain Rehabilitation 
Program has two different care options, both lasting 5 weeks.71 The first option is a full-day (6 hours) or 
partial-day (3 hours) daily program.71 The Brooks facility focuses on functional restoration with therapy 
reactivation, reducing catastrophizing and fear avoidance behavior, enhancing internal locus of control, 
and detoxification of opioid medications.71 In a study, Brooks Pain Rehabilitation Program evaluated 
patient outcome pre-program, post-program, and long-term (3 months, 6 months, 9 months, 12 
months, 24 months).71 Data was collected from the patients after completing the program. After 
completion of the program, range-of motion of specific joints were measured, and a specific follow-up 
tool was developed to monitor changes in patients.71 According to the 6-month follow-up data, an 
overall level of activity and ability to perform daily activities of life progressed or continued at improved 
levels in nine of the ten patients. Pain levels also decreased or stayed the same for three of four 
patients, and emotional distress decreased by nearly 50%.71  
An interdisciplinary clinic located in Chicago, Illinois evaluates 1000 new patients per year.71 The 
Rehabilitation Institute of Chicago Center for Pain Management evaluates a patient for 3 to 4.5 hours 
before admission.71 If the patient is a candidate for treatment, the patient has a variety of program 
options.71 Patients may participate in a 4-week (full program), 8 hour per day program that runs from 
Monday through Friday.71 The other pain program option is 4 weeks with a modified 4 hour per day.71 
Both program options include physical therapy and occupational therapy, relaxation training, pain 
psychology, nursing education, opioid detoxification, medical management and group therapy.71 All 
patients have a 4 week followed-up after completing a treatment program. The Chicago Center for Pain 





Improvements were noted in patients’ functional status at discharge, 6 months and 1 year after 
participation in the rehabilitation program.71  
 Interdisciplinary rehabilitation programs do not target a specific anatomic source of pain but 
addresses the physical, psychological, emotional, social, and professional needs to treat chronic 
disorders.24 As noted in the three interdisciplinary rehabilitation programs discussed earlier, 
interdisciplinary rehabilitation programs are associated with improvements in pain and function for 
chronic pain patients.31  Even though the American Pain Society has described components for a 
successful interdisciplinary rehabilitation facility, programs still vary.13 Interdisciplinary rehabilitation 
programs are effective however, the features of the program that are responsible for improvement have 
yet to be clarified.63 Some authors argue that the psychological factors play the greatest role in 
successful outcomes in rehabilitation.34  Another author assumes changes in coping strategies and 
beliefs are the most critical aspect of interdisciplinary rehabilitation programs.70  
 A barrier of interdisciplinary programs is the subjective evaluations of patients and how patients 
are separated into treatment groups. As seen in all three rehabilitation programs mentioned previously, 
patients were examined and evaluated differently.  Each clinic used different tools, questionnaires and 
scales to evaluate pre and post treatment. An objective evaluation needs to be implemented in 
conjunction with self-reports for determining what rehabilitation group is appropriate for the patient. 
Self-report measures do not adequately capture the changes in habitual activity patterns after pain 
interventions and therefore need to be used in conjunction with objective measures.28 17, 18  Another 
barrier of intensive interdisciplinary rehabilitation programs, is the high cost and limited insurance 
coverage.13 Some chronic pain patients need insurance companies and government assistance to pay for 
the rehabilitation program. Third-party payers need significant information on treatment plans, 
treatment methods and outcomes to assess treatment effectiveness.81 Education to third-party 





from coverage.81 Along with the subjective evaluation given to third-party payers, an objective 
evaluation of the patient’s day and night activity level can be given. 
For Chronic pain patients, physical activity is disrupted due to pain and it has long been 
theorized that the relief of pain is accompanied by improvement in function.20 The two main studies that 
support the relationship between physical activity and pain intensity were completed in 1981 and 
1990.51, 62 However, more recently the relationship between pain intensity and physical activity is 
described as modestly associated.80 One possible reason for the difference in results in previous 
research are the different methods used for measuring movement. Some studies have used self-report 
questionnaires to determine activity. Others have used objective function measures including the six 
minute walk.  However, in chronic pain patients their self-awareness of movement and pain is known to 
be disrupted. Therefore, more studies are needed that measures function in chronic pain patients using 
objective measures of movement and activity. Objectively measuring day and night movement are 
difficult for patients to conceal and/or alter. As a result of the relationship between day and night 
activities with chronic pain, an objective measurement based on these can help patients receive 
continued support from third-party supporters. In addition, supplying this information to third-party 
payers will help demonstrate that the patient does in fact need an interdisciplinary rehabilitation 
program. 
Clinical Prediction Rule  
 Clinical prediction rules have been developed to determine what patients respond to a 
particular treatment.32 Clinical prediction rules are used every day and are designed to assist clinical 
decision making when caring for patients.54 Clinical prediction rules assist decision making for using 
imaging on patients with ankle, knee, cervical, spine or minor head injuries.72-74 Furthermore, clinical 
prediction rules have not only been developed for diagnosing, but for predicting an individual’s response 





structures to treat chronic pain. Researchers are unaware as to what aspects (psychological or coping 
strategies) are the most influential in treating chronic pain, suggesting that interdisciplinary programs 
can benefit from a clinical prediction rule.  
 Recently, a clinical prediction rule was developed to see who would respond to spinal 
manipulative therapy for the treatment of low back pain (LBP).23 A trial was performed to validate the 
spinal manipulation clinical prediction rule.12 One hundred and thirty-one patients with LBP participated 
in the study and were between the ages of 18-60 years.12 Patients completed self-reported 
measurements such as the Fear-Avoidance Beliefs Questionnaire (FABQ) and pain rating scale.12 Physical 
therapists were blinded, but examined the patients’ range of motion, hip internal rotation and assessed 
the 5 criteria in the spinal manipulation clinical prediction rule.12 To further minimize bias, physical 
therapists were unaware of the patients’ status on the clinical prediction rule.12 The 5 criteria in the 
spinal manipulation clinical prediction rule assesses the duration of low back pain, extent of distal 
symptoms, fear-avoidance beliefs and hip internal range of motion.12 To be considered positive on the 
rule, patients must of met 4 of the 5 criteria: current duration of low back pain is ˂16 days or less, no 
distal pain below the knee, fear-avoidance belief score of ˂19, hypo-mobile lumbar spine, and ˃35 
degrees of internal range of motion.12 
After examinations, patients were assigned to one of two groups.12 Seventy patients were 
randomly assigned to the first group that consisted of spinal manipulation plus an exercise treatment.12 
Sixty-one patients were assigned to the second group that consisted solely of an exercise treatment.12 
Patients in both groups attended physical therapy twice during the first week and then once a week for 
the next three weeks.12 
As previously mentioned, patients who met at least 4 of the 5 criteria were considered positive 
on the rule.12 The results suggested patients who were positive on the rule and treated with 





were negative on the rule and received manipulation.12 These results were maintained at the 6 month 
follow-up.12 Furthermore, patients who were positive on the rule and received manipulation 
experienced greater improvements after 1 and 4 weeks than patients who were positive on the rule and 
received exercise intervention.12 At the 6 month follow up, patients in the exercise group demonstrated 
greater medication use, health care utilization and more time off work due to back pain.12 Patients who 
were positive on the rule and treated with spinal manipulations had a 92% chance of achieving a 
successful outcome by the end of 1 week.12 Patients with fewer than 3 criteria would have only a 7% 
probability of success, indicating the need for alternative treatment.12   
There is no clinical prediction rule for treating chronic pain.  Developing a clinical prediction rule 
for chronic pain can potentially save the yearly cost that is attributed to treating chronic pain. Not all 
chronic pain patients have the same pain causing condition. However, the connection between chronic 
pain, physical activity, and sleep disturbances gives the potential for using activity and movement during 
the night as a potential clinical prediction rule for chronic pain. Assessing a patient’s day and night 
activity could assist a clinician’s decision on what treatment group is appropriate for the individual.  
Hopefully, measuring day activity level, night movement, and subjective questionnaires can be used in 
developing a clinical prediction rule to assist interdisciplinary rehabilitation programs with consistent 
results.  
Specialized (S) and Super Specialized (SP) groups of the self-management 
chronic pain program 
One of the few chronic pain programs in Montreal is housed at the Constance Lethbridge 
Rehabilitation Centre (CLRC). The program is a 9-week interdisciplinary rehabilitation program for 
chronic pain patients. While other chronic pain programs focus on the reduction of pain medication as 





interdisciplinary cognitive behavior approach. Some of the CLRC clinicians describe the program as a 
self-management program because the goal is not to treat the disease or condition the patient is 
suffering from. The clinician’s goals focus on personal goals for the patient and managing their life with 
pain. The main goal for the rehabilitation program is not to decrease the patient’s pain but improve to 
function for activities of daily living. The interdisciplinary program’s main approach is targeting risk 
factors for chronicity. The CLRC objective is to improve self-management skills in daily activities, 
psychological function, behavior reversal, and increase daily physical activities.  People with chronic pain 
must first meet certain criteria to become a client of CLRC. The person must be 18 years or older, be 
referred from a physician with a precise medical diagnosis and neuromusculoskeletal disability, require 
interdisciplinary or adaptation rehabilitation, have a medically stable condition that will not interfere 
with rehabilitation, and must be able to participate actively in an individual or group rehabilitation 
approach.   
The CLRC has two interdisciplinary rehabilitation treatment groups; a specialized (S) and a super- 
specialized program (SP). To determine what group is appropriate for the individual, further screening is 
needed. Once the participant is accepted as a client, he or she is evaluated by a CLRC doctor to 
determine what treatment group is appropriate for the individual. Both the S and SP groups are 
intensive rehabilitation programs, but the SP group is more intensive than the S group. The SP group 
receives treatment 4x per week from 9:00am-2:30pm while the S group receives treatment 2x per week 
from 8:45am-12:00pm. Tables 1 and 2 for a sample week schedule for the S and SP groups. Despite the 
frequency and daily duration, the objectives and activities of both groups are the same (Refer to Table 3 
for a list of all activities).  
S Group: Week Monday Tuesday Wednesday Thursday  Friday 


















Table 1: S group week schedule. 
SP Group: 
Week 





































Table 2: SP group week schedule.  
Program Activities for the S and SP Groups 











Managing emotions and fears 
Communication and problem solving 
Nutrition 
Table 3: List of topics addressed for the S and SP group during the 9-week program.  
Actigraphy and Activity 
Symptoms of pain, fatigue and depression produce a complex relationship between sleep and 
chronic pain patients.42 However, it is difficult to interpret descriptions of fatigue from subjective 
measurements.42 There is no objective tool for measuring fatigue, but measuring levels of activity during 
the day can provide an objective indication of impaired physical functioning among chronic pain 





Understanding how consumed a chronic pain patient is by their pain, it is important to determine their 
daily activity.  
 Before determining daily activity levels of chronic pain patients, activity parameters need to be 
defined and understood for the actigraphy. When using an actigraphy, a sedentary minute is when the 
monitor output < 100 counts per minute.53 The ability for the actigraphy to distinguish between 
postures (sitting vs. standing) is important because some standing activities can be or are below 100 
counts per minute and not considered sedentary.44 Activities such as folding laundry and washing dishes 
are examples of standing activities where the counts per minute are below 100 but are not considered 
sedentary.44 However, the ability of the actigraphy to differentiate between sedentary time and light 
activity is unknown.43  
 To determine if the actigraphy is able to distinguish between sedentary and non-sedentary 
activities, a wrist actigraphy was compared to the activPAL.43 An activPAL is a tool designed to measure 
living activity, has the ability to differentiate among postures and classify an individual’s activity into 
time sitting, standing and stepping.43 The activPAL has been validated in a laboratory setting compared 
with direct observation and was found to be 100% accurate for measuring sitting, standing, and 
walking.30 Although the activPAL has been validated in a laboratory setting, the activPAL has not been 
validated in a free-living setting compared to direct observation.43 The aim of the study comparing the 
activPAL versus actigraphy was to validate the actigraphy at 100 counts per minute and the activPAL for 
assessing sedentary behavior.  
 The sample included 5 males and 15 females who were overweight or obese and who 
participated in <3 days a week of moderate activity for 20 minutes in the last 6 months.43 All participants 
completed two 7-day conditions.43 Participants were instructed to wear the monitors during all waking 
hours.43 The first condition was baseline measurements where participants maintained a normal level of 





participants completing tasks that reduced sitting time.43 Standing during commercial breaks or taking a 
5 minutes standing/walking break for each hour of work were strategies given to participants to 
decrease sedentary time and increase light-intensity activities.43 Also, participants had to complete daily 
and hourly checklist tasks to break up sitting time and to ensure compliance.43 During both conditions, 
participants were directly observed once for 6 hours in their free-living environment.43 
 The results of the study showed that, on average, both the activPAL and 100 count per minute 
actigraphy underestimated sedentary time compared with direct observation.43The activPAL 
underestimated sitting time by 2.8% and the 100 count per minute actigraphy underestimated sitting 
time by 4.9%43. The 150 count per minute actigraphy had the lowest bias of 1.8%.43 Although the 150 
count per minute actigraphy had the lowest bias for monitors, the actigraphy was not sensitive to 
distinguishing between sedentary and active conditions.43  
 The current study supports the activPAL as an accurate and precise monitor for measuring 
sedentary behaviors and is sensitive to distinguishing between sedentary and active conditions.43  Also, 
the results suggest the 150 count per minute actigraphy provided better estimates of sedentary 
behavior than the 100 count per minute actigraphy and the activPAL.43. However, the actigraphy is not 
as precise at distinguishing sedentary and active conditions.43  
Even though the activPAL is able to differentiate an individual’s activity into sitting, standing and 
stepping, an actigraphy will be used for the proposed study. The 150 count per minute actigraphy is 
more accurate in determining sedentary behavior and registers slight movement such as folding laundry 
and washing dishes. Determining if a patient sits, stands or steps more is not important for the proposed 
study as long as activity or the lack of activity is recorded. Actigraphy is a very diverse tool and will be 
used for this study to determine how much chronic pain patients move throughout the day as well as 





A study was done on chronic pain patients to determine daily activity level. A comparison of 
patients with fibromyalgia without depression, fibromyalgia with depression, depression alone, and 
healthy controls was performed.42 The healthy control group was comprised of 28 women with a mean 
age of 53.4 (±2.4) years.42 The fibromyalgia without depression group had 16 patients all women with a 
mean age of 49.2 (±2.4) years.42 Four men and five women made the depression alone group with a 
mean age of 45.8 (±2.7) years.42 The fibromyalgia with depression groups had one man and five women 
with a mean age of 48 (±2.4) years.42  
 An actigraphy wristwatch was worn on the non-dominant arm for 7 days and data was recorded 
every minute.42 Subjects also had to keep a sleep diary, recording sleep-wake time as well as activities.42 
The mean of daytime activity levels, nighttime activity levels, and percentage of time spent asleep 
during the daytime and nighttime were calculated from the actigraphy to determine level of activity.42  
 The control group’s results after seven days showed a consistent and regular sleep-wake cycle 
with high activity levels during the day.42 Also, the control group showed uninterrupted periods of sleep 
at night with a sleep efficiency of 92.3%.42 The fibromyalgia patients showed similar levels of daytime 
activity to normal controls, but showed signs of disturbed sleep with significant increased levels of 
activity at night.42 Fibromyalgia patients had a sleep efficiency of 89.16%.42 The patients in the 
depression group showed signs of disturbed sleep, significant increased levels of nighttime activity and 
decreased sleep efficiency of 73.48%.42 The group of patients with fibromyalgia and depression showed 
impairment with reduced daytime activity, significant increase in time spent sleeping during the day and 
more sleep interruption and movement during the night.42 Depressed fibromyalgia patients had a sleep 
efficiency of 78.85%.42 
 This study demonstrated that the actigraphy is a useful tool not only to measure sleep patterns 
but activity levels among chronic pain patients as well. Measuring chronic pain patients’ daytime and 





patient. At the CLRC, patients are separated into the specialized (S) or super specialized (SP) group. Both 
groups are assigned into intensive rehabilitation programs but the SP group is more intensive than the S 
group and patients are separated into either group by subjective evaluations and interviews. As a result 
of the recall effect from patients when filling out subjective questionnaires, objective and subjective 
measurements, and as both correlate modestly with each other, therefore both measurements should 
be used 59. For my study, subjective and objective measurements will be used to determine patient 
placement in rehabilitation programs and program success. 
Actigraphy and Night Movement 
 In laboratory settings, polysomnography (PSG) is considered the “gold standard” for diagnosing 
sleep disturbances but actigraphy is commonly used as an alternative for some variables.22 The PSG 
gathers data about oximetry, airflow, heart rate fluctuations, snoring, movement of the ribs and 
abdominal area, and electrical activity through electroencephalography and electromyogram.21 An 
actigraphy is a small body-mounted device capable of collecting data while individuals are living in their 
natural environment. The sampling is more representative pattern of daily activity.28 Furthermore, the 
actigraphy is a well validated, low-cost alternative technology for assessing sleep disorders.49 Due to the 
expense of equipment, laboratory settings, technicians and the “first night” effect in healthy populations 
not suffering from sleep disturbances, an actigraphy will be used for this study.39, 48  
The actigraphy is a watch that contains an accelerometer that records movement throughout 
the day.78 The actigraphy determines the sleep-wake measures by comparing the amount of movement 
to the amount of lack of movement.65 Actigraphy correlates well with the polysomnography in 
measuring sleep parameters.11 When worn on the non-dominant wrist, the actigraphy has shown to 
have very good interunit reliability (r=0.98).28 Furthermore, the reliability has been shown to be constant 





The actigraphy has not only been compared to Polysomnography (PSG), but the The actigraphy 
has been analyzed by units worn at different body sites (intersite reliability) and units worn at the same 
site (interunit reliability).28 In a 2-hour trial, a study was designed to evaluated interunit and intersite 
reliability by attaching two units at each site: wrist, waist, and ankle 28. In this case, an actigraphy was 
attached to the non-dominate side of each subject.28 From a pool of 20 units, 6 units were randomly 
chosen for testing.28 The actigraphy placement was rotated across the three subjects so no actigraphy 
was tested at the same site twice and no pair was matched more than once.28 The three subjects being 
tested (2 males and 1 female), were instructed to perform normal daily activities.28  For the two male 
subjects, the study was conducted during household chores and activities that included cleaning, 
sweeping, reading, and working at the computer.28 For the female subject, the study was performed 
during routine clinical-care activities that included reviewing charts, examining patients, walking 
between examination rooms and the front desk.28  
The interunit coefficients revealed excellent agreement between matched units within each 
placement site.28 The intersite coefficients indicated that the waist and ankle activity measurements 
were highly correlated (r=0.97 ± 0.01),28 whereas, the wrist measurement demonstrated a more modest 
agreement with the waist (r= 0.56 ± 0.03) and ankle (r= 0.58 ± 0.06).28 The results of the study indicated, 
that the actigraphy has excellent interunit reliability and good validity when used at any of the three 
potential locations.28  
In the same study, the actigraphy validity was measured. The validity of the actigraphy was 
tested during the study by measuring 3-D movement using the VICON system. Only one of the three 
subjects was tested.28 The ability of the actigraphy to evaluate 3-D movement was done during two 15 
minutes trials. The first trial consisted of lumbar stabilization exercises that included pelvic tilts, bridges, 





commonly prescribed for back pain rehabilitation.28 The second trial consisted of walking at a pace of 
one meter/second.28  
The validity results showed that the counts of wrist and waist placement during the lumbar 
exercises were highly correlated with the VICON measurements and that the ankle placement was 
moderately correlated with the VICON.28 During the walking trial, the actigraphy located at the waist 
and ankle demonstrated excellent association with the VICON and the wrist placement was moderately 
correlated with the VICON.28 
The validity of the actigraphy during the lumbar exercises and walking trials suggests that the 
placement site be considered when measuring activity for greatest accuracy of measurement.28 The 
ankle and waist actigraphy placement provided better measurements during walking activity, while the 
wrist and waist actigraphy placement were better measurements during lumbar exercises.28 For my 
research study, a wrist actigraphy was used because chronic pain patients do not perform strenuous 
activities throughout the day and many studies that measure movement on chronic pain patients use a 
wrist actigraphy to gather information. The next section goes into greater detail about chronic pain 
patient and movement.  
The actigraphy measures sleep onset (SOL), total sleep time (TST), wake after sleep onset 
(WASO) and sleep efficiency (SE).65 Sleep onset latency (SOL) is the amount of time an individual takes to 
fall asleep after going to bed, measured by immobility.11 Total sleep time (TST) is the time spent sleeping 
during the sleep interval.39 The time spent awake after falling asleep until the final awakening is the 
wake after sleep onset (WASO).38 Sleep efficiency is the total sleep time achieved from sleep onset to 
final awakening and is represented as a percentage.65 
 A sleep diary is used in conjunction with actigraphy.39 A sleep diary is used to note bedtime, 
wake-up time, naps and times when the watch is removed for bathing purposes.39 Bedtime components 





The Pittsburgh Sleep Diary (PghSD) is a tool that measures daily activity and perceived sleep measures.58 
These measures include sleep duration, WASO, sleep quality, waking mood and alertness.58. The PghSD 
is very reliable, with high inter-test correlation.58 I will use the PghSD to compare bedtime, number of 
wake times during the night, perceived sleep quality and mood and alertness from day to day.  
Furthermore, the journal serves as a reference for the actigraphy to explain longer term inactivity. 
For the purpose of my study, a wrist actigraphy was used to collect sleep measurements from 
chronic pain patients. From the information mentioned previously, the actigraphy has a high interunit 
reliability, is a reliable tool to measure sleep without interfering with patient daily routine and is a cost 
effective method for collecting sleep measurements. 
Chronic Pain and Night Movement 
 Research suggests at least 50-88% of patients with chronic pain disorders have significant sleep 
complaints.68 Patients with rheumatoid arthritis, fibromyalgia and LBP are well known to have sleep 
disturbances.69  In the United States alone, the number conservatively translates to 28 million Americans 
with chronic pain who complain of sleep disturbances.68 Research suggests chronic pain and disturbed 
sleep are interconnected.56 Pain interferes with sleep, but sleep disturbances also influence the 
experience of pain.56 However, research is unable to conclude if sleep disturbances are a cause or a 
consequence of chronic pain.55 Even though researchers can’t conclude if sleep disturbances are a cause 
or an effect,  research suggest there is a direct relationship between the intensity of pain and the degree 
of sleep disturbances.52 
 Chronic pain patients report more pain, pay more attention to the pain and have poorer sleep.1 
A day with more attention to pain was followed by a poorer night’s sleep, and a more disturbed night’s 
sleep was followed by a day with more attention to pain.1 The relationship between sleep and pain 
means sleep deprivation and poor sleep quality can lower pain thresholds and the mental capacity to 





mood, daytime function and general quality of life.56 Chronic pain patients are more anxious and 
depressed.66 Chronic pain patients create a self-perpetuating cycle of sleep disturbances, increased pain 
and depression.56 The next three sections go into more depth of the relationship between three chronic 
pain conditions and sleep.  
Rheumatoid Arthritis and Night Movement 
The prevalence of sleep disturbances have been very high in rheumatoid arthritis (RA) 
patients.19 The prevalence of sleep disturbances among rheumatoid arthritis patient is 75%.64 A several 
night actigraphy study was performed on patients with RA, LBP patients and healthy controls to 
determine the movement or sleep-wake behavior of chronic pain patients.46 The study consisted of 13 
women with RA, 9 women with LBP, and 12 healthy control women.46 All participants wore the 
actigraphy for 7 nights, wearing the watch at bedtime and removing the watch when they woke.46 LBP 
and RA participants were not taking non-steroidal anti-inflammatories (NSAIDs) or any medication that 
could affect their sleep.46 Healthy controls were not on any medications.46 The researchers concluded 
RA patients have periodic limb movements, more sleep disturbances, and decreased sleep efficiency 
compared to the control and LBP subjects.46 Sleep disturbances among RA was associated with 
overnight increase in tenderness in peripheral joints and in the non-articular tender points typically 
found in fibromyalgia.57  
Another study compared a self-report fatigue on adults with RA and healthy controls to 
determine the relationship of fatigue to pain, sleep, functional status and depressive symptoms.6 A 
sample of 51 patients with RA was compared to 46 sex matched controls without RA.6 Patients 
completed self-administered questionnaire 3 times at 6-8 week intervals.6 The questionnaires included 
Multidimensional Assessment of Fatigue Scale, Sleep Survey, Health Assessment Questionnaire and 





with RA.6 The study concluded patients with RA are strongly associated with fatigue, poor sleep, 
functional disability, greater joint pain, and more depression in comparison to healthy controls.6  
The two previously mentioned studies distinguish the close relationship between sleep and 
chronic pain. Furthermore, the studies demonstrate the common occurrence of sleep disturbances 
among chronic pain patients.  As a result of the prevalence of sleep disturbances in chronic pain 
patients, measuring sleep efficiency among chronic pain patients is a good objective evaluation to use to 
determine the effect or influence chronic pain has on the patient. 
Fibromyalgia and Night Movement 
Sleep has been studied immensely with patients who suffer from fibromyalgia. Sleep difficulties, 
fatigue and morning stiffness have been reported in >75% of patients with fibromyalgia.19 Furthermore, 
the prevalence of awakening and non-restorative sleep is reported more in fibromyalgia patients than 
RA patients.19 A greater number of tender points were in fibromyalgia patients due to poorer sleep 
because the sleep quality was associated with musculoskeletal tenderness.36  
 A study on fibromyalgia patients was performed to examine the association between subjective 
sleep quality and pain threshold.2 Sixteen patient (13 females and 3 males) with fibromyalgia were 
included in this study 2. Sensory testing was determined by a manual algometer.2 Two consecutive trials 
assessed mechanical pain threshold on 4 fingers of the non-dominate hand.2  Sleep quality was assessed 
by the Pittsburgh Sleep Quality Index (PSQI). The PSQI was administered to assess the sleep quality of 
the patients during the previous month.2 The study concluded the subjective quality of sleep in 
fibromyalgia patients was inversely related to pressure pain sensitivity.2 In other words, increased pain 
sensitivity is associated with greater sleep disturbances.2 
This study shows the importance of evaluating the subjective sleep quality on chronic pain 
patients. The PSQI is a reliable tool to measure subjective sleep quality. The PSQI will be administered 





and once after completing the program). The PSQI is one more element to show patient improvement in 
the rehabilitation program. Measuring the subjective sleep evaluation before and after will help 
determine the effect the program has on sleep.  
Low Back Pain (LBP) and Night Movement 
Low back pain is the most common of all musculoskeletal disorders among adults.56 In an 
actigraphy study mentioned previously,  which measured sleep-wake behavior in LBP, concluded LBP 
patients did not significantly differ from RA  patients in the number of sleep wake transitions.46 The 
results of the study suggest patients with LBP didn’t move as often as the RA patients at night, but LBP 
patients did not have as refreshing sleep as the healthy controls. The results of the previous study are 
similar to another actigraphy study conducted on LBP patients. The actigraphy recorded longer 
awakenings and patients reported more disturbed and un-refreshing sleep in comparison to the healthy 
control.10  
A longitudinal prospective behavioral study was carried out on LBP patients.16 The study was 
conducted on 148 workers who suffered from a soft tissue back strain or sprain and did not returned to 
work within 3 months.16 The workers were interviewed at 3, 6, 9, 15, and 21 months after sustaining the 
injury.16 The workers were assessed by the McGill Pain Scale Questionnaire, visual analogue scale, 
University of Alabama Pain Behavior Scale, pain threshold, sleep complaint questionnaire, psychological 
distress questionnaire, and functional and social disabilities and handicaps.16 The results of the study 
suggested functional disability and psychological distress were negatively associated with the rate of 
return to work.16 Also, if workers were positive on the distress scale they were one-and-a-half times less 
likely to return to work.16 Furthermore, the subjects who did not return to work at 21 months post-
injury were more likely to have increased sleep complaints, diffuse pain, fatigue, and psychological 





As explained in the previous studies, subjective and objective measuring tools have been used 
to determine sleep disturbances among chronic pain patients, however the number or frequency of 
sleep disturbances have not been used as a tool to determine patient placement in a rehabilitation 
program. Additionally, sleep disturbances have not been used to determine if patients who have more 
sleep disturbances have a lower success rate in a rehabilitation programs. For this study, improvements 
in pain related fear and function will be calculated to determine success rate.  My research study will 
use reliable subjective questionnaires to measure pain related fear, function, depression, and pain, as 
well as an actigraphy to measure objective evaluations of day time and night time movement to predict 
patient placement. In addition, the measures will be used to determine the successful outcome of 
interdisciplinary rehabilitation. 
Objectives and Hypotheses 
1) The first objective of this study was to measure the change in pain related fear, physical function, 
depression, and pain at baseline and upon completion of the 9-week chronic pain program and 
compare the changes between the S and SP groups.  
Hypothesis:  All participants will experience an improvement in pain related fear, physical 
function, and depression with no significant change in pain. In addition and based on 
preliminary data, we hypothesize that there will be no difference between groups for any 
variable.  
2) The second objective of this study was to use actigraphy to measure movement (during the day 
and at night) in all participants prior to starting the 9-week program and compare all movement 
variables between the S and SP groups.  
Hypothesis: The SP group will move less during the day and more during the night compared to 





3) The third objective was to assess the relationship between movement during the day and at night 
to the baseline measures of pain related fear, function, depression, and pain.  
Hypothesis a): There will be a negative correlation between movement during the day and pain 
related fear, depression, and pain and a positive correlation with function.  
Hypothesis b): There will be a positive correlation between movement at night and pain related 
fear, depression, and pain with an associated negative correlation to function.  
4) The fourth objective was to assess the relationship between movement during the day and at 
night to the change from baseline to completion of the 9-week program in pain related fear, 
function, depression, and pain.  
Hypothesis a): There will be a negative correlation between the amount of movement during 
the day and the change in pain related fear, function, depression, and pain.  
Hypothesis b): There will be a positive correlation between movement at night and the change 
in pain related fear, function, depression, and pain.  
Methods: 
Subjects 
We approached 40 chronic pain subjects at the CLRC. All participants were on the CLRC wait list 
prior to starting their 9-week rehabilitation program. Participants suffered from a variety of chronic pain 
conditions including fibromyalgia, LBP, shoulder pain, arthritis, and pain due to occupational accidents.  
Subjects were asked to refrain from alcohol during the period the actigraphy was worn. Participants 
were excluded from the study if they consumed recreational drugs, have clinically diagnosed sleep 
disorders, seasonal affective disorders, or if they were on a prescribed sleep aid regiment.  In addition, 





actigraphy use, and religious concerns. Therefore, a total of 24 subjects participated (17 females and 7 
males) in our study (age=48.1±11.8years, weight=76.2±21.2kg, height=164.6±7.3cm). Twelve subjects 
were in the specialized group (S) and 12 in the super specialized group (SP).   
Pain related fear 
 We assessed the subjects’ pain related fear prior to and upon completion of the 9-week 
program. We used three self-report questionnaires to measure the amount of catastrophizing (PCS), 
kinesiphobia (TSK), and perceived injustice (IEQ).  
The TSK is a 17-item questionnaire that assesses a patient’s fear of movement or (re)injury.41  A 
high scoring TSK indicates a high degree of kinesiophobia 41. The total scores ranges from 17 to 68 with a 
value of 37 or higher as indicative of a high score.41 
The PCS assesses catastrophizing which is a negative mental state brought on by actual or an 
anticipated painful experience.76 The 13-item questionnaire asks participants to reflect how they feel 
and what they think when they are experiencing pain.76 The PCS total score is calculated by summing all 
items. It ranges from 0-52 and a score of 30 indicates catastrophizing.76 
The IEQ evaluates the perceived injustice or unfairness associated with injury.75  The scoring is 
done by summing all 12 items and the range is from 0 to 48. A score of 30 or higher is considered to be 
high.75  
Physical Function 
 Physical functioning is the ability to perform tasks or activities and we assessed this two ways 
(subjectively and objectively). We used a self-report questionnaire (PDI) to measure function 
subjectively and the 6-minute walk test to measure physical function objectively. We measured the PDI 





The PDI discriminates between patients with low and high levels of disability.77 Participants rate 
how pain interferes with functioning in family/home, responsibilities, recreation, social activities, 
occupation, sexual behaviors, self-care, and life-support activities.77 The PDI ranges from a score of 0-70. 
A higher score on the index, the greater the person’s disability due to pain.77 
The 6-minute walk test was administered to assess physical capabilities of the patients.40 
Patients performed the test twice, once before the start of the 9-week rehabilitation program and once 
after completing the rehabilitation program.40 The 6-minute walk test was measured in meters. 
Depression 
We measured depression using two scales; the PHQ-9 and the BECK depression inventory. We 
measured the patients’ levels of depression at the beginning and at the end of the 9-week program.  
The PHQ-9 is a 10 item questionnaire that assesses depression.27 A score of 10-14 indicates 
moderate depression, 15-19 moderately severe depression, and 20-27 severe depression.27 In addition, 
the BECK depression inventory measures the severity of a person’s depression.5 The highest possible 
score is 63.5 A score of 10-18 indicates mild depression, 19-29 moderate depression and a score greater 
than 30 indicates severe depression.5  
Pain 
 We used the McGill Pain Questionnaire to assess pain. This self-reporting questionnaire allows 
patients to describe the quality and intensity of their pain.7 The McGill Pain Scale Questionnaire is 
composed of 78 words and scoring ranges from 0-78.7 
Movement during the day 
Patients were given an actigraphy to measure movement prior to starting the 9-week 





throughout the day and night. The actigraphy was worn 24 hours a day for 7 days, except for bathing 
purposes. The watch was worn by the participants on their non-dominate wrist.  The actigraphy was set 
to a 1 minute epoch length and low wake threshold. The participants were informed that we were 
measuring movement at night but we did not tell them the watch was also recording the movement 
during the day. This was done to ensure an accurate representation of movement during the day prior 
to the program.  
Patients filled out a diary for 7 days, at least twice a day. They recorded the time they woke up 
and the time they went to bed in order to have an accurate measurement of their awake time during 
the day for the calculation of movement for the actigraphy.8 The diary was used to match the actigraphy 
data in order to create more accurate intervals of participants’ wake and sleep time variables. Patients 
were instructed to write in the dairy the time they “went to bed” and the “lights out” time. Went to bed 
was defined as the time the participant went to bed but was not actively trying to fall asleep, reading or 
watching TV. Lights out was determined as the time the participant turned out the lights and attempted 
sleep.  We identified on the actigraphy what time the watch indicated the subject went to bed. Then we 
checked the diary to see what time the subject indicated they turned the lights out and attempted 
sleep.  This ensured that we used “lights out” as the correct time for actual sleep instead of starting the 
calculation when the participant was not actively attempting sleep. Furthermore, participants recorded 
in the dairy the number of wakes throughout the night, reason for waking, sleep quality, alertness on 
final wakening and mood on final wakening.8 Naps were permitted during the data collection period, but 
participants recorded the time in the diary. Moreover, if and when the actigraphy was removed for 
bathing purposes or any other reasons, patients indicated the time in the dairy. The amount of wake 
time that was indicated by movement on the actigraphy was confirmed by the activity description in the 





actigraphy was excluded from the daytime intervals. However, any naps the participant took over the 
course of the day were not excluded. 
The activity variables include movement efficiency, total wake time, minutes of movement, and 
mean activity level. Movement efficiency is expressed as a percent and is defined as to what extent how 
active a person is throughout the day. A simple ratio was used to calculate the movement efficiency. 
Movement efficiency was determined by dividing the minutes of movement by the total wake time 
minutes then multiplied by 100 to get a percentage. The higher the percentage of movement efficiency, 
the more physically active the person is. Total wake time was determined for each day by using the 
sleep diary and calculating the time the participant woke up to the time they went to bed. Minutes of 
movement were calculated by the amount of movement that actually occurred during the entire time 
they were awake.  Mean activity was calculated as the mean number of activity counts per minute 
during each daytime wake period. Physical activity for patients was assessed across the wear of the 
actigraphy and activity levels were compared between groups.  
Movement during the night 
The actigraphy determines the sleep-wake measures by comparing the amount of movement to 
the amount of lack of movement. As mentioned earlier, we used the diary in order to have accurate 
total sleep times for all the patients. Sleep variables that were calculated from the actigraphy were: 
sleep efficiency (SE), total sleep time (TST), and wake after sleep onset (WASO). SE is expressed as a 
percent and a SE less than 85% is considered to be indicative of sleep disturbance.67 TST is the total 
amount of time spent asleep from sleep onset to final awakening. WASO is referred to the time spent 





6-Minute Walk Test: 
 Physical function is assessed by the 6-minute walk test. The 6-minute walk test is a safe, reliable 
and valid measurement for assessing patients’ physical function.29 Subjects walk at a fast but 
comfortable pace for 6 minutes.29 The 6-minute walk test assesses the submaximal cardiorespiratory 
level of patients.15 The test has been used for pre and post evaluation and for measuring the response to 
therapeutic interventions.15 In my study, the distance the patient covers in 6 minutes will be recorded 
and be compared to their 6-minute walk test after completion of the 9-week rehabilitation program.  
Procedures 
1)  Participants were contacted by a CLRC employee and were given details about the study. After 
agreeing to participate in the study, subjects were informed that the purpose of the study was 
to evaluate sleep performance and measure movement during sleep. Participants were asked to 
bring a printed list of medication they were prescribed to the first meeting with the researcher.  
Participants were not informed that their daily activity would be monitored in order to get a 
true representation of their normal daily activity.  
2) Upon the first meeting, participants read and sign a consent form providing written details 
about the purpose, procedures, risk and contact numbers in case they have questions 
throughout the study duration.  Also, patients were presented with the benefits of participating 
in the study.  
3) As mentioned previously, patients filled out the questionnaires and performed the 6-minute 
walk test. This process took about one hour for each participant. 
4) Subjects received an actigraphy set at 1 minute epoch length and low wake threshold, and a 
sleep diary. Participants were told how and when to fill out the diary as well as when to remove 





5) Participants were given the rules for the next 7 days while the actigraphy was worn. Subjects 
were informed to follow their regular daily routines. Caffeine and tobacco were permitted for 
the course of the study if the participant consumed them on a regular basis. However, alcohol 
and illicit drugs were not permitted during the 7 days of testing. 
6) Exercise was permitted as long as the participant performed them on a regular base. 
Participants were permitted to nap during the study. 
7) Upon completion of the 7 day study, subjects returned the actigraphy and sleep diary. Then the 
subjects started the 9-week program in either the S or the SP program. At this time the data 
from the actigraphy was uploaded to a computer and analyzed. 
8) After completing the 9-week rehabilitation, participants met with the researcher again, 
completed the 6-minute walk test and filled out the previously mentioned questionnaires. The 
questionnaires and 6-minute walk results were compared from those taken before the program 
began. Furthermore, participants were asked if they were still taking the same medications and 
dosage as at the start of the program.   
Statistical Analysis  
1) The first objective was to measure and compare the changes in pain related fear, function, 
depression, and pain upon completion of the 9-week program between the S and SP groups. To 
determine this, 8 separate 2X2 ANOVAs were performed. A separate ANOVA was used to 
identify differences in the: PCS, TSK, IEQ, PHQ-9, BECK, PDI, 6-minute walk test, and McGill Pain 
Scale between the S and SP groups.  
2) The second objective of the study was to compare the movement between the S and SP groups 
during the day and at night. There were two groups (S and SP) and 6 days of movement during 





used to identify differences between movement efficiency, total wake time, mean minutes of 
movement, and mean activity level between the S and SP groups. In addition, the two groups (S 
and SP) and 5-nights of movement were analyzed to determine differences. Hence, 2X5 ANOVAs 
were used to identify differences in movement at night and sleep, which included sleep 
efficiency (SE), total sleep time (TST) and wake after sleep onset (WASO) between the two 
groups (S and SP). 
3)  The third objective of the study was to determine if the amount of movement during the day in 
chronic pain patients was related to poorer initial scores in pain related fear, function, 
depression, and pain.  To complete this objective, Pearson correlations were performed on all 
movement variables (movement efficiency, total wake time, mean minutes of movement, and 
mean activity levels) to baseline scores of TSK, PCS, IEQ, PDI, 6-minute walk test, PHQ-9, BECK 
and the McGill Pain Scale. In addition, more Pearson correlations were completed to assess the 
relationship between movement at night (SE, TST, WASO) and the baseline measures of TSK, 
PCS, IEQ, PDI, 6-minute walk test, PHQ-9, BECK and the McGill Pain Scale. 
4)  The fourth objective of the study was to determine if chronic pain patient’s movement prior to 
the program can predict a successful completion of the chronic pain program. A successful 
completion of the program would be a large decrease in pain, pain related fear, function, and 
depression. So again, we used Pearson correlations to determine the relationships between all 
movement variables (movement efficiency, total wake time, mean minutes of movement, and 
mean activity levels) to the change in scores of the TSK, PCS, IEQ, PDI, 6-minute walk test, PHQ-
9, BECK, and McGill Pain Scale. Moreover, we used Pearson correlations to identify relationships 
between movement at night (SE, TST, WASO) and the changes in TSK, PCS, IEQ, PDI, 6-minute 






Our first objective was to determine the efficacy of the program or the amount of improvement in 
pain related fear, function, depression, and pain between the beginning and the end of the program. In 
addition, we wanted to identify any differences between the S and SP groups at baseline and upon 
completion of the program. There were significant time effects for all variables except for pain for all 
patients, indicating an improvement in all measures except for pain. However, there were two variables 
that had a significant group by time differences indicating a difference in improvement between the two 
groups.   
1) Efficacy of the Program and S vs. SP Difference  
A) Pain-Related Fear 
The PCS decreased significantly in all participants from baseline to 9 weeks (F (1, 11) = 53.7, p= 
˂.001). The initial PCS for the SP group was 30±7.5 and the final 15.6±13.1. The initial PCS for the S group 
was 31.4±17.5 and the final was 23.4±17.5. Moreover, participants’ kinesiophobia significantly 
decreased after completing the 9-week program, which was measured by the TSK. The TSK was the first 
variable that had a significant group by time effect (F (1, 11) = 5.0, p= .048). The average initial TSK for 
the SP group was 46.9±3.1 and the final was 35.2±11.2. The initial TSK for the S group was 44.2±10, with 
a final of 40.7±8.4. The significant group by time effect suggests that the SP group had less 
kinesiophobia than the S group at the completion of the 9-week program. The IEQ, the third pain related 
fear questionnaire, also significantly decreased from baseline to 9 weeks (F (1, 11) =5.8, p= .035), but 





Figure 1: Average baseline and final catastrophizing scores for the S and SP groups (*indicates 
statistically significant relationship p<0.05). 
 
 











































The self-report measurement of function (PDI) significantly improved at 9 weeks (F (1, 11) = 
40.8, p˂.001).  The initial SP group PDI was 41.7±8.4 and the final was 28.7±13.8. The S group initial 
was 44.7± and the final was 29±18. Participants’ function was also measured objectively using the 6 
minute walk test. The 6 minute walk test was the second variable that had a significant group by 
time effect (F (1, 11) =5.5, p= .041). The significant group by time effect suggests that the SP group 






















Figure 4: Initial and final subjective function results for the S and SP groups (*indicates 
statistically significant relationship p<0.05). 
 
 
Figure 5: Baseline and final objective function results for the S and SP groups (*indicates 
statistically significant relationship p<0.05). 
 
C) Depression 
Participants suffered from less depression after completing the 9-week program. The initial 
scores for depression on the PHQ-9 for the SP group 14.9±6 and the final was 8.9±6. The S group 





























used to measure the severity of depression. After completing the 9-week program, there was a 
significant improvement in the severity of depression in all participants (F (1, 11) =10.4, p=.012).  
 
Figure 6: Average initial and final depression scores for the S and SP groups (*indicates 
statistically significant relationship p<0.05). 
 
 
Figure 7: Average initial and final severity depression scores for the S and SP groups 







































The McGill Pain Scale measured quality and intensity of pain and was the only variable that did 
not change significantly for either group. The average initial pain level for the SP group was 36±10 
and the final was 34.4±14.7. The initial pain level for the S group was 36.2±16.9 and the final was 




Figure 8: No change between baseline and final McGill Pain Scale scores for the S and SP groups.  
 
2) Movement Comparison Between S and SP  
A) Movement During the Day 
Using the methods mentioned previously on how to calculate participants’ physical activity, 
their six-day mean activity was calculated then separate 2X6 ANOVA’s was used to compare the two 
groups over the 6 days of activity. In order to make physical activity calculations more accurate, every 
participant’s first day of physical activity was excluded from the data due to the varying times 
participants received the actiwatch on the first day. Participants’ physical activity was calculated from 
day two through day seven.  The mean six day movement efficiency for both of the groups was 84% (SP 
















=.091, p=.769) (See figure 12).  Furthermore, there was no statistical significant difference in total wake 
time between the groups (F= (1, 11) .539, p=.480). The total wake time for the SP group was 
856.5±151.5 and S group 896±94 (See Figure 13). The average minutes of movement for the SP group 
was 721.6±151.1 and the S group was 738.1±122.2 (F= (1, 11) .127, p=.729) (See figure 14). The six day 
mean activity level for the SP group was 347.3±119.9 and 353.1±137.8 for the S group (F= (1, 11) 0.17, 
p=.989) (See figure 15). 
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Figure 13: The average total wake time over six days of actigraphy usage. 
 
 





















































Figure 15: The average mean activity level for both groups over six days. 
 
Groups Movement Efficiency Total Wake Time Minutes of Movement Mean Activity Level 
SP 84.4±10.9 857.8±86.3 713.6±94.6 331.9±107.5 
S 83.4±7.6 875.1±74 729.2±103.7 343.7±130.9 
Table 4: S and SP daily activity.  
B)  Movement at night 
Participants’ movement at night was analyzed across five nights instead of seven due some 
participants not being compliant with wearing the watch. Instead of analyzing over 7 days and having 
missing data for some participants, we chose to eliminate day 6 and 7, primarily because those are the 
days the participants removed the watch. Each group’s SE, TST, and WASO were averaged over the 5 
nights then separate 2X5 ANOVA’s were used to compare the movement at night between the groups. 
There was no statistical difference for sleep efficiency (SE) between the S and the SP group (See figure 
6). The SP group mean SE was 82.6%±7.7and S 81±8.8 (F (1, 11) =.238, p=.635). Furthermore, there was 
no statistical difference between the groups in total sleep time (TST) (See figure 7). The mean TST for 























p=.967). A statistical difference between the groups for wake after sleep onset (WASO) was not found 
(See figure 8). The SP group’s mean WASO was 89.9±62.2 and the S group’s mean WASO was 96.1±58.5 
(F (1, 11) = .082, p=.780).  
 
Figure 9: Average sleep efficiency for each group across the five nights 
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Figure 11: Average WASO for each group over the five nights. 
 
Groups SE TST WASO 
SP 82.6±7.7 405.5±34.2 89.9±62.2 
S 81±8.8 406.6±79.5 96.1±58.5 
Table 5: S and SP night time movement.  
3) Movement Correlated to Initial Pain Related Fear, Function, Depression, 
and Pain 
Many correlations were calculated to determine if there was a relationship between movement 
during the day and movement at night with the initial results of pain related fear, depression, function 
and pain. There were a few statistically significant relationships identified (See tables 6-9).  
A) Movement Correlated to Initial Pain-Related Fear 
The relationships between movement during the day and movement at night and all pain 
related fear measures were examined. No significant relationships were found between the PCS, 
TSK, and IEQ with any of the day movement or night movement variables (see table 6). 
Initial Scores PCS TSK IEQ 
Movement Efficiency -.283 -.067 -.095 
Total Wake Time -.108 .001 -.183 
Minutes of Movement -.263 -.040 -.172 
Mean Activity Level -.214 -.096 -.101 


























TST .020 .014 .097 
WASO .274 .169 .357 
Table 6: Pearson correlations between movement during the day and at night with initial 
scores in pain related fear (r values, *indicates statistically significant relationship p<0.05). 
 
B) Movement Correlated to Initial Function 
The relationships between movement during the day and movement at night and all 
subjective and objective measures were examined. Three strong correlations were identified 
(See table 7). There was a strong negative relationship between movement efficiency and the 
initial Pain Disability Index (PDI) questionnaire (R= -.500, p= .013).  Another strong negative 
relationship was noted between the six-day mean activity level, measured by the actiwatch, and 
the PDI (R=-.427, p= .038). The third strong negative relationship was identified between 
minutes of movement and initial PDI (R= -.522, p=.009). 
Initial Scores PDI 6-minute 
walk test 
Movement Efficiency -.500* .120 
Total Wake Time -.262 .044 
Minutes of Movement -.522* .121 
Mean Activity Level -.427* .327 
SE -.098 .007 
TST .207 .120 
WASO .123 .065 
Table 7: Pearson correlations between movement during the day and at night with initial scores in 
function (r values, *indicates statistically significant relationship p<0.05). 
 
C) Movement Correlated to Initial Depression 
Two strong negative relationships were found between minutes of movement and total 
wake time with initial depression (See table 8). A strong negative relationship was found 
between total wake time and initial PHQ-9 (R= -.445, p= .029). The second strong negative 
relationship was found between minutes of movement and the initial PHQ-9 (R= -.467, p=.021).  
Initial Scores PHQ-9 BECK 
Movement Efficiency -.264 -.388 





Minutes of Movement -.467* .373 
Mean Activity Level -.258 -.273 
SE -.143 .044 
TST .237 .284 
WASO .191 -.056 
Table 8: Pearson correlations between movement during the day and at night with initial scores in 
depression (r values, *indicates statistically significant relationship p<0.05). 
 
D) Movement Correlated to Initial Pain 
Two daily movement variables had a statistically significant relationship with initial pain (See 
table 9). Total Wake Time had a strong negative relationship with initial pain (R= -.505, p= .014) 
and minutes of movement had a strong positive relationship with the initial McGill Pain Scale 
(R= -.552, p= .006). 
Initial Scores McGill 
Movement Efficiency -.317 
Total Wake Time -.505* 
Minutes of Movement -.552* 




Table 9: Pearson correlations between movement during the day and at night with initial scores in 
pain (r values, *indicates statistically significant relationship p<0.05). 
 
4) Movement and Change in Pain Related Fear, Function, Depression, and 
Pain  
To determine if movement during the day or at night was related to a change in pain related 
fear, function, depression and pain at the completion of a chronic pain program, more correlations 
were performed.  One strong relationship was found (See tables 12). 
A) Initial Movement Correlated to Change in Pain-Related Fear 
Initial movement during the day and movement at night variables were correlated to change in 
pain related fear scores. No significant relationships were found between initial activity and 





Change in Scores ΔPCS ΔTSK ΔIEQ 
Movement Efficiency -.206 -.179 .010 
Total Wake Time -.129 -.227 -.079 
Minutes of Movement -.250 -.299 -.047 
Mean Activity Level -.188 -.127 .105 
SE -.195 -.060 .168 
TST -.116 -.065 .153 
WASO .217 .105 -.118 
Table 10: Pearson correlations between movement during the day and at night with changes in 
pain related fear (r values, *indicates statistically significant relationship p<0.05). 
 
B) Initial Movement Correlated to Change in Function 
Movement during the day and movement at night were correlated to the change in subjective 
and objective function (See table 11). No significant relationships were found between movement 
during the day and at night with the change in PDI or the 6MWT. 
Change in Scores ΔPDI Δ6-minute 
walk test 
Movement Efficiency -.321 .141 
Total Wake Time -.117 .239 
Minutes of Movement -.325 .264 
Mean Activity Level -.212 .222 
SE -.142 .089 
TST -.108 -.094 
WASO .188 -.137 
Table 11: Pearson correlations between movement during the day and at night with changes in 
function (r values, *indicates statistically significant relationship p<0.05). 
 
C) Initial Movement Correlated to Change in Depression 
Movement during the day and movement at night were correlated to the change in 
depression (See table 12). One strong correlation was noted. A strong negative relationship was 
identified between total wake time and change in PHQ-9 (R= -.452, p=.026). 
 
Change in Scores ΔPHQ-9 ΔBECK 
Movement Efficiency -.014 -.335 
Total Wake Time -.452* -.067 
Minutes of Movement -.322 -.280 
Mean Activity Level -.101 -.394 
SE .029 .139 





WASO .031 -.244 
Table 12: Pearson correlations between movement during the day and at night with changes in 
depression scores (r values, *indicates statistically significant relationship p<0.05). 
 
D) Initial Movement Correlated to Change in Pain 
Movement during the day and movement at night were correlated to the change in pain 
after completing the 9-week program (See table 13). No significant relationship was found 
between the McGill Pain Scale and any movement variable. 
Change in Scores ΔMcGill 
Movement Efficiency .154 
Total Wake Time .220 
Minutes of Movement .235 




Table 13: Pearson correlations between movement during the day and at night with changes 
in pain (r values, *indicates statistically significant relationship p<0.05). 
 
Discussion: 
1) Program Efficacy and difference between S and SP group  
 
Our first objective was to evaluate the efficacy of the treatment of chronic pain after completing a 9-
week rehabilitation program at the CLRC. The results of our study supported our first hypothesis; the 9-
week interdisciplinary rehabilitation program decreased pain related fear, increased function, and 
decreased depression in the participants. There were significant decreases from baseline measurements 
to completion of the 9-week program in PCS, TSK, IEQ, PDI, 6-minute walk test, PHQ-9, and the BECK for 
all subjects. However, there was no significant reduction in pain after completing the rehabilitation 
program. Participants went through a 9-week chronic pain rehabilitation program, but there was no 





levels, participants had significant improvements in depression and function, which could be due to the 
improvements in their psychological factors and pain related fear. Regardless of the specific injury or 
condition between patients, all subjects were rehabilitated in a similar fashion at the CLRC and the 
lesion site was not addressed throughout the 9-week rehabilitation. The CLRC’s primary focus was to 
address the psychological factors of chronic pain. Our findings are supported by recent research with 
regards to treating chronic pain, it is more important to treat the psychological factors of pain than to 
treat the lesion site.25 
One of the key pain related fear measures in our study was catastrophizing measured by the PCS. 
The change from initial PCS score to the final PCS score after the completion of treatment is an 
important tool used to measure success of this particular program. By decreasing the patient’s pain 
related fear, it decreases the subject’s catastrophizing which in turn changes how the patient views 
their pain. In changing how a patient views their pain, it decreases movement avoidance behaviors and 
may lead to increase patient function. A decrease in the PCS may be the reason for more function as 
well as less depression in these patients. The average initial PCS for the patients of this study was 30.7 
±13.2, which is very high. For example, the average initial PCS for patients at the Mayo Clinic Pain 
Rehabilitation Program was 23.3±11.5.79 Furthermore, those patients at the Mayo Clinic were also 
receiving opioid medication to treat their pain.79 Moreover, the non-taking opioid patients at the Mayo 
Clinic average PCS score was 25.3±13.1.79 At the completion of our study, our participants’ average PCS 
dropped to 19.5±15.6. This approximate 11 point improvement is similar to Mayo Clinic study.79 The 
average PCS final for the patients at the Mayo Clinic who were taking opioids improved to 12.9±11 
whereas the non-opioid patients decreased to 12.2±12.3.79 The CLRC and the Mayo Clinic Pain 
Rehabilitation had different methods of addressing chronic pain, but both programs addressed the pain 
related fear and had similar decreases in the PCS. As mentioned previously the average pain did not 





because of the reduction of catastrophizing and movement avoidance behaviors. Addressing 
catastrophizing is an important factor in chronic pain programs and should continue to be addressed. 
Another important measurement tool for chronic rehabilitation programs are self-report functional 
assessments questionnaires. The Pain Disability Index (PDI) is a common questionnaire used to assess 
participants’ physical functioning. In a similar program from a study in 2010 at the Rehabilitation 
Institute of Chicago Center for Pain Management, participant’s average initial PDI was 41.2 and the 
final PDI, after completing an interdisciplinary treatment program, was 18.71 The initial PDI average for 
the current study was 43.2±11.3 and the final average was 28.9±15.7.  The subjects’ change in PDI in 
our program was not as significant compared to the Chicago program. The possibility why there was 
not as significant increase in function, measured by the PDI, can be due to the CLRC program not 
focusing on medication reduction or because patients started treatment with a higher initial PCS score. 
In addition, the patients in our program may have more comorbid conditions including depression and 
anxiety, which may limit the amount of improvement in self-reported function.  
 Both the Mayo and Chicago Rehabilitation Centers place an emphasis on medication management 
and reduction where the CLRC does not. The treatment protocol at the CLRC is non-pharmacological 
based program, emphasizing the self-management of chronic pain. Moreover, the CLRC program is a 
multidisciplinary cognitive behavior approach as well as occupational therapy. The goal for the 
rehabilitation program is to improve function for activities of daily living, which may explain why the 
pain related fear decreases at the end of the 9-week program. Despite program variations regarding 
pain medications, treatment strategies, and baseline levels of pain related fear, patients in our study 






The significant improvements in the psychosocial factors (PCS, TSK, IEQ, PDI, PHQ-9, and BECK) 
noted in the CLRC participants could be attributed to the amount of education that occurred 
throughout the 9-week program. Evidence-based education of chronic pain reduces the threat and fear 
of chronic pain and encourages coping strategies.25 In a previous study, exercise and psychosocial 
education was used to lower the incidence of LBP in soldiers.25 In that study, a cluster randomization 
strategy was utilized to sort 4,147 soldiers with no previous history of LBP.25 Participants were divided 
into four interventions comprised of exercise and education programs (traditional lumbar exercise, 
traditional lumbar exercise plus psychosocial education, core stabilization exercise, core stabilization 
exercise plus psychosocial education).25 The traditional and core exercise regimens were composed of 5 
exercises each and performed for 5 minutes a day, 5 days per week for 12-weeks.25 The psychosocial 
education program consisted of a 45 minutes lecture.25 The lecture included information about the 
importance of returning to normal activity, decreasing fear-avoidance beliefs, and decreasing pain 
catastrophizing when experiencing pain.26 Over the course of two years, 706 soldiers had LBP and the 
groups that had a lower incidence of LBP were seen in the traditional lumbar exercise plus psychosocial 
education and core stabilization exercise plus psychosocial education.25 The results of this study 
suggest that education can help decrease the future development of chronic pain. The results from our 
study suggest that education can also reduce pain related fear and improve function in patients 
currently experiencing chronic pain. The George et al. study demonstrated that patient education alone 
was able to generate a decrease in the development of chronic low back pain.25 Therefore, education 
about pain related fear is a critical aspect of treating chronic pain. The patient education is emphasized 
throughout the 9-week self-management rehabilitation program at CLRC. The program covered topics 
that include what chronic pain is, stress and chronic pain, managing stress, thoughts, emotions and 





program which is specific to chronic pain and as a result may be the key reason for the significant 
decreases in kinesiophobia, catastrophizing, and depression in our subjects. 
2) Movement Comparison between the S vs SP 
A) Movement during Day 
The second objective was to assess the physical activity in chronic pain patients in the S and SP 
groups. We hypothesized that the SP participants would have less activity compared to the S group and 
we made this hypothesis based on our preliminary data. However, our hypothesis was not supported.  
There were no differences identified between the groups for any physical activity variables that were 
calculated.  
We calculated mean activity level in a similar fashion to previous studies and the 6-day mean activity 
level for the SP group was 347.3±119.9 and 353.1±137.8 for the S group. The mean activity level 
calculated for our participants varied from other studies. One study found that the mean activity level in 
adolescents with chronic pain was 464.8±150.6,84 while another study found a mean activity of 415± 
112.50 Both studies noted a slightly higher level of activity in healthy adolescents of 515±111 and 
517±115.3.50, 84  It is likely that the increase in activity observed in these studies was due to the younger 
participants compared to our study.  
The mean activity results of our study were higher in comparison to a study performed on adults 
with chronic low back pain (cLBP). Participants wore a wrist actigraphy, epoch set at 15 seconds, during 
waking hours for 5 days and entered pain severity in a diary every 4-hours.3 The actigraphy data was 
analyzed and the average mean activity per 4-hour period was calculated.3 The average mean physical 
activity for the participants with cLBP which was measured every 4-hours over 5 days was 228.2±80.1.3 





other research has shown participants who have more depression have less activity.42 The difference in 
epoch length could also contribute to a lower activity count compared to our study.   
In addition to depression, another study measured physical activity in subjects suffering from 
bipolar disorder.37 Sixty adults with bipolar disorder wore a hip accelerometer at a 1 minute epoch for 
seven consecutive nights.37 Adult bipolar disorder participants were matched by gender, age, and body 
mass index to users and non-users of mental health treatment.37 The majority of the bipolar adults had 
moderate depression symptoms.37 The study determined the mean activity level for bipolar disorder 
patients to be 159.3±87.2 and their minute per day activity was 229±87.37 The group that included 
mental health treatment mean activity level was 238.4±114.1 and minute per day activity was 
328±115.37 The participants who did not receive mental health treatment mean activity level was 
295.9±121.0 and minute per day activity was 379±107.37 Our participants’ mean minutes of movement 
for the SP group was 721.6±151.1 and the S was 738.1±122.2.37 The study concluded that bipolar 
disordered adults have less activity and are more sedentary than users and non-users of mental health 
treatment.37 Bipolar adults had two thirds of activity levels of users of mental health.37 Comparing the 
activity levels of the two studies is difficult due to the fact that the accelerometer was placed at 
different locations, but the bipolar adults had moderate depression levels and the study found they 
moved less. The participants in our study have high depression levels which could explain the low 
activity levels.  
Determining if the participants of our study have a low activity level is difficult to conclude due to 
the fact there is little research done on physical activity in adults with chronic pain. More studies need 
to be conducted on adults with chronic pain using the same actigraphy methods to determine their 
accurate levels of activity. Previous studies that used actigraphy to measure physical activity on 





movement. Our study is among the first to report these physical activity variables in chronic pain 
patients. Therefore, further investigation is warranted to determine if the calculations reported in this 
study can be improved upon with treatment.  
B) Movement at Night 
With the use of an actigraphy, we were able to measure various sleep quality variables in adults with 
chronic pain. Part B of our second objective was to evaluate the movement at night in chronic pain 
patients in the S and SP group. Based on our preliminary data, we hypothesized the SP group would 
have more movement at night (more sleep disturbances) compared to the S group. The results from our 
study do not support our initial hypothesis; there is no statistical difference in any movement at night 
variable between groups. The average sleep efficiency for both groups is approximately 82%, which a 
sleep efficiency of 85% or less is considered to be poor sleep.  
The sleep efficiency gathered from our study, varied to other studies that used actigraphy to 
measure sleep quality in participants with chronic pain. A seven-night actigraphy study was performed 
on adolescents and their SE was 76.1%.61 Another study, performed on adults aged 45-53 with 
fibromyalgia and depression, reported a sleep efficiency of 78.85%. 42 Within the fibromyalgia study, 
sleep quality was assessed on participants who had fibromyalgia only and the sleep efficiency reported 
was higher at 89.16%.42 In another seven night sleep study, chronic pain patients age and gender were 
matched to healthy controls, the reported sleep efficiency was 88.3% for cLBP participants and 87.8% 
for healthy controls.82 The Palermo et al. study that measured the low (76.1%) SE in adolescents, did not 
assess if participants were diagnosed with a sleeping disorder prior to participating. It is possible that 
subjects with sleep disorders would have a decreased SE that may not be related to their chronic pain. 
Prior to allowing patients to participate in our study, they were asked if they have a history of sleep 
apnea or any clinically diagnosed sleep disorders. Also, the study that measured participants who had 





assess depression or the average level of depression among participants. It is possible that subjects with 
high levels of depression could alter the results of the sleep assessment. However, we learned from the 
study that depression plays a key role in sleep quality because the participants who only had depression 
had the lowest SE (73.4%) compared to everyone else.42 Comparing the depression levels found from 
our study to the Korszun et al. study would have been interesting and may have explained the difference 
in SE between the subjects. While it seems apparent that pain negatively affects sleep, it seems even 
more apparent that pain in addition with pain related fear significantly decreases sleep quality. As noted 
in our study and previous studies, there is a significant decrease in sleep quality with an association of 
depression.61 Based on the results from our study, pain related fear, like depression, negatively affects 
sleep significantly more than pain alone. A more accurate assessment of sleep using polysomnography is 
needed to determine if sleep is decreased more in patients with paint related fear and pain compared to 
depression alone.  
Chronic pain patients often complain of sleep disturbances.60, 69  Pain interferes with sleep and sleep 
disturbances have a direct influence on pain experienced. As mentioned before, chronic pain patients 
have increased pain sensitivity and create a self-perpetuating cycle of sleep disruption, increase pain 
and depression. Previous studies have showed that patients with fibromyalgia demonstrate increase 
body sensitivity, both physiologically and psychologically.4  Patients with fibromyalgia experience more 
alpha electroencephalographic (EEG) interruption in non-rapid eye movement sleep, indicating an 
increase level of arousal.4 The prominent alpha EEG sleep may contribute to unrefreshing sleep and help 
to re-enforce the perpetual pain-sleep cycle fibromyalgia patients experience.4 As suggested above, 






Similar to our sleep efficiency, the total sleep time (TST) of our study was lower compared to 
previous research. The TST for the SP group was 405.5±34.2 and TST for the S group was 406.6±79.5. 
Other studies reported higher averages, a pilot study using actigraphy to measure sleep in cLBP 
compared to healthy controls found a TST of 434.33±76.9 for pain patients.60 Another study performed 
on cLBP patients reported a TST of 441.2±68.5 for CLBP.82  Wake after sleep onset (WASO) is another 
variable calculated from the actigraphy and is expressed in minutes. The actigraphy calculates how many 
minutes the participant is awake after initially falling asleep through movement. The WASO results 
recorded in our study were significantly higher compared to other research.  The mean WASO for the SP 
group was 89.9±62.2 and S group mean WASO was 96.1±58.5. Other research has reported levels of 
WASO of 43.3±15 and 35.5±12.4 in patients which cLBP.60, 82 As mentioned above, there is a possibility 
that the combination of pain, pain related fear and depression is what significantly affects the WASO in 
these patients.  
3) Movement Correlated to Initial Pain Related Fear, Function, Depression, 
and Pain 
Our third objective was to evaluate if chronic pain patients with less movement during the day and 
more movement during the night have poorer initial scores in pain related fear, function, depression, 
and pain.  We hypothesized that the patients with less day movement and more night movement would 
have higher baseline levels of pain related fear, less function, less depression, and more pain. The results 
of our study did not support our third hypothesis. Movement during the day did not correlate to any of 
the initial pain related fear questionnaires. Movement efficiency, minutes of movement and activity 
level were significantly correlated to the PDI. In addition, total wake time and minutes of movement 
were significantly correlated to the PHQ-9. Lastly, total wake time and minutes of movement correlated 
to initial pain levels.  Night movement did not correlate to any initial pain related fear, function, 





A) Movement Correlated to Initial Function 
 An interesting finding from the study was that movement efficiency, minutes of movement, and 
mean activity level correlated to the initial PDI but not to the initial 6 minute walk test. The correlation 
between movement efficiency and initial PDI was R= -.500, p=.009, minutes of movement and initial PDI 
was R= -.522, p= .009, and mean activity level and initial PDI was R= -.427, p=.037. This is an interesting 
finding because three objective measurements correlate to a subjective evaluation of physical activity 
(PDI) but not to another objective evaluation of physical activity (6 minute walk test). For example, 
people with lower movement efficiency, minutes of movement, and mean activity level were associated 
to a lower initial PDI score but not necessarily a lower initial 6-minute walk test. The data suggests that 
people who feel like they are not that functional do not move that much and report that they do not 
move that much. However, if we test them to see how much they can move, they move well. These 
patients are choosing not to move, which could contribute to their prolonged rehabilitation. Moreover, 
our study suggests that when patients complete the PDI, their score will indicate their amount of activity 
but not what type of function or activity they are capable of performing. Our data supports using both 
subjective and objective measurements of physical activity to identify how much activity the patients 
are participating in as well as their actual capabilities.  
 The objective measurement of physical activity not correlating to self-reported function has been 
reported in previous research.47 A study was performed to determine the relationship among self-
reported activity limitations and clinician measured functional performance.47 Eighty-three patients with 
LBP filled out the Roland-Morris Disability Questionnaire (RMDQ) and completed six physical 
performance measures  (lumbar flexion, 50-foot walk at fastest speed, 5-minute walk, 5 repetitions of sit 
to stand, 10 repetitions of trunk flexion and loaded reach task).47 The RMDQ is similar to the PDI 
because it is another subjective measurement of function and the six physical tasks are objective 





corresponding performance (R= .20 to .33).47 The findings from this study do not correlate with the 
findings of our study. The correlation between movement efficiency and 6-minute walk test for our 
study was R= .120 and minutes of movement and 6-minute walk test was R= .121. The differences in the 
relationship between self-reported function and specific activity tasks may be due to the elevated pain 
related fear in our subjects. Psychological questionnaires were not mentioned in the study, but previous 
research has found psychological variables can explain the variance between self-report limitations and 
performance measures.9 The psychological variables include fear-avoidance beliefs, psychological 
disturbances, and catastrophizing. Another study reported stronger correlations between psychological 
factors and subjective measurements than psychological factors and observed function with patients 
with acute LBP.83  
 The findings of our study support previous research that subjective measurements correlate more 
to activity limitations than objective measurements. Movement efficiency, minutes of movement, and 
mean activity level correlates with the subjective evaluation (PDI) and not the objective evaluation (6-
minute walk test). Physical functioning is multidimensional, which includes an individual’s subjective 
perception of their physical function and perceived difficulties performing activities.84 Clinicians at the 
CLRC has described the difficulty with communicating with patients. Clinicians ask chronic pain patients 
to perform a task and patients immediately say they are unable, but clinicians know that physically the 
patients are able to complete the task, however they are just choosing not to, which is similar to their 
movement or lack of movement outside the clinic.  
Neither self-reported activity nor objective performance measure is a pure measurement of physical 
functioning when used alone.47 Both measurements (subjective and objective measures of function) are 
affected by physical and psychological factors and each measurement provides information to construct 
physical function.47 As result of these findings, further investigation is needed to measure the 





B) Movement Correlated to Initial Depression and Pain 
Minutes of movement and total wake time correlated with initial PHQ-9 and pain. The correlation 
between minutes of movement and initial PHQ-9 was R= -.467, p= .021 and total wake time and initial 
PHQ-9 was R= -.445, p= .029. The negative correlation found between minutes of movement, total wake 
time and depression means participants who moved less and had shorter total wake time and also were 
experiencing more depression. As mentioned previously, depression has an influence on day time 
activity and our results are congruent with other research.42 37 We also noted a significant negative 
correlation between the McGill Pain Scale and minutes of movement and total wake time. The higher 
the initial pain level, the less minutes of movement patients had throughout the day and the less total 
wake time. Higher initial pain levels correlating negatively to minutes of movement and total wake time 
could be explained by psychological factors that are associated with pain. Patients have a fear of 
movement because they believe if they move it will cause them more pain (catastrophizing) which 
results in less minutes of movement.  
A longitudinal study was performed to evaluate the influence of depression and pain intensity on 
self-report and objective measurements of physical activity on cLBP patients.35 Sixty-six cLBP patients 
between the ages of 18-65 participated in a 14 day study.35 Participants’ activity levels were monitored 
using actigraphy for 14 days and an electronic diary that patients were required to fill out describing 
their daily activity.35 Patients had to complete the diary 8 times a day, every time the diary’s alarm 
sounded.35 Prior to the actigraphy measurements, patients answered questionnaires that assessed their 
disability, habitual physical activity, pain intensity, and depression.35 The Roland Morris Disability 
Questionnaire (RMDQ) assessed subjective function and the Baecke Physical Activity Questionnaire 
assessed subjective habitual activity.35 The BECK Depression Inventory assessed depression and the 
Visual analogue scales determined pain intensity.35 The results of the study suggest that depression was 





levels of subjective physical activity in daily life compared to their actual level of physical activity.35 
However, depression was significantly associated with the discrepancy between self-report and 
objective assessment of physical activity.35 In that study, pain intensity was not associated with patients’ 
daily activity level.35 The study was able to conclude that cLBP patients, who have higher levels of 
depression, underestimate their subjective daily activity, although their objective level of activity did not 
differ and pain intensity does not influence activity level.35 The results of the study differed from our 
study in that two objective measurements of activity correlated to depression. The severity of 
depression can be the explanation as to why there is a difference between the two studies. Patients at 
the CLRC had significantly higher depression levels in comparison to the other study. The initial BECK 
depression level, for both groups, at the CLRC was 22.1±15.6 whereas; the other study’s average BECK 
depression was 11±15. As mentioned previously, higher depression levels influence daily activity.37, 42 
The reason as to why pain intensity was not associated with the level of daily activity in the other study 
but a correlation was found in our study could be due to the level of pain intensity and pain related fear. 
The CLRC patients had very high pain intensity which was assessed by the McGill Pain Scale. 
Furthermore, the other study failed to mention the pain related fear levels of their participants, which 
plays a key role in function. Based on the results of our findings, the level of depression and pain 
intensity both influence daily activity. 
4) Movement related to the Change in Pain Related Fear, Function, 
Depression, and Pain  
Determining if day or night movement can predict outcomes in pain related fear, function, 
depression, and pain at the completion of a chronic pain rehabilitation program was our fourth objective 
for this study. We predicted patients with less movement during the day and more movement at night 
would be associated with smaller changes in pain related fear, function, depression, and pain. The 





study was between total wake time and change in PHQ-9 (R= -.452, p= .026). This moderate correlation 
suggests participants who initially had a higher total wake times were associated with a greater change 
in depression at the completion of the program. 
 A recent study was conducted to assess the strongest predictor of physical activity for chronic pain.3 
The study examined if fear-avoidance, operant, and pain could predict physical activity for chronic pain 
patients.3 Patients completed questionnaires that assessed their depression, catastrophizing, 
kinesiophobia, psychosocial variables, and pain sensitivity.3 After, participants wore a wrist actigraphy 
with the epoch set at 15 seconds, during waking hours for five days and entered pain severity every 4-
hours.3 The actigraphy data was analyzed and the average activity counts per minute over 4-hour 
periods were calculated.3 The results of the study revealed that the response of the patients’ spouses 
accounted for a significant amount of variance in physical activity, meaning reinforcement of behaviors 
from a spouse is a powerful mechanism for behavior change.3 The results from our study are congruent 
with this study in the fact that the PCS, TSK, IEQ, PDI, PHQ-9, and BECK did not correlate to physical 
activity. The finding that patients’ spouses accounted for a significant variance in physical activity could 
be confirmed by our study because the responses of spouses were not assessed. 
As previously mentioned, correlating change in pain to all other variables was not part of our initial 
hypothesis. However, because pain can be considered a baseline or outcome measurement, we 
correlated the change in pain to the initial day and night movement, change in pain related fear, 
function, and depression. The change in pain was not correlated to day or night movement, pain related 
fear, function, or depression. Further investigation is needed to determine what factors can contribute 






 There are several limitations to this study that should be noted.  The first limitation is the lack of 
consistency of the program coordinator at the CLRC. There were more than 4 clinical coordinators 
during the course of this study who were involved in determining patient placement within the groups. 
Not having a consistent person in the selection process may have affected the homogeneity of the 
patients in the S and SP groups. Another limitation of the study was the time of year participants were 
monitored with the actigraphy. Participants were recruited throughout an entire year and the amount of 
day light may have affected the total sleep time of patients. In addition, patients were not always 
compliant in describing their prescribed medication use. We anticipated that some participants used 
some medication without reporting it, which may have affected their movement at night.  
Conclusion:  
In conclusion, this study suggests that an interdisciplinary program that focuses on the self-
management of chronic pain is effective in reducing pain related fear, and improving physical function, 
and depression. There was no statistical difference between the two groups at the CLRC for any 
movement during the day or night variables. This study mentioned new variables that can be used to 
help determine physical activity of adults with chronic pain in future studies. Our movement during the 
day and movement efficiency data has helped to establish baseline levels of physical function for adults 
with chronic pain. However, objective measures of movement during the day or night were unable to 
predict the successful completion of a chronic pain program. Although, movement efficiency, minutes of 
movement, and total wake time correlated to self-reported function (PDI), but not to another objective 
measure of function (6-minute walk test). Furthermore, minutes of movement and total wake time 
correlated to initial values of depression (PHQ-9) and pain (McGill Pain Scale). Total wake time was also 





Clinicians should use self-report and objective functional measures to measure activity in 
chronic pain patients to determine how capable they are and how much activity they are partaking in. 
More research is needed to determine if depression and pain intensity influence daily physical activity. 
Future research should investigate why movement efficiency, minutes of movement, and mean activity 
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  As mentioned previously, participants’ sleep was analyzed across five nights instead of seven 
due some participants not being compliant with wearing the watch. Sleep on-set latency (SOL) is the 
fourth variable the actigraphy is capable of calculating. Each groups’ sleep quality was averaged over the 
five nights then a 2X5 ANOVA was performed, comparing the groups to nights of sleep.  Along-side SE, 
WASO, and TST, sleep onset latency is objectively derived from the actigraphy. Sleep onset latency is 
defined as the length of time, measured in minutes, the patient takes to accomplish the transition from 
full wakefulness to sleep.2 The time period measure from “lights out” to the beginning of sleep is SOL.1 
Each groups’ sleep quality was averaged over the five nights then a 2X5 ANOVA was performed, 
comparing the groups to nights of sleep. There was so statistical difference for SOL between the SP and 
S group (See figure 11 and 12). The SP group SOL was 18.9±25.5 and S group SOL was 25.1±32.9 (F (1, 
11) =.321, p= .572). 
 



























Figure 2: No difference between the groups for the average five day SOL 
 



































Figure 4: No difference between groups for the average five day total sleep time.  
 
Figure 5: There was no significance of average six day movement efficiency between groups. The 






























Figure 6: There was not statistical difference between groups for average six day total wake time. 
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